5. Bone Matters: Osteoporosis and its Echo on Lifespan in Sjögren’s Patients
Sjögren’s syndrome, beyond the tear and salivary glands, has skeletal implications that aren’t often brought to the forefront. Osteoporosis is one such consequence that has noteworthy repercussions on life expectancy.
Osteoporosis is characterized by a reduction in bone density. This means that bones become more fragile, heightening the risk of fractures. A fracture, especially in the later stages of life, can have severe implications, including reduced mobility and potential complications from surgeries or long bed rest.
The connection between Sjögren’s and osteoporosis isn’t entirely clear. Some theories point to the inflammation-causing cells that may interfere with the bone-rebuilding process. Furthermore, the steroid medications often prescribed to manage Sjögren’s symptoms can lead to decreased bone density over time.
The life expectancy equation, in this case, isn’t just about bone fractures. Reduced mobility can result in secondary health challenges like deep vein thrombosis or pulmonary embolism. These conditions can, in severe cases, be fatal.
Awareness is half the battle. Regular bone density tests, especially for post-menopausal women with Sjögren’s, can be lifesaving. Contemporary treatments, including bisphosphonates, can help maintain bone density, ensuring a stronger skeletal structure even with the presence of Sjögren’s. (5)
